The Medicines Company Reports First-Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Medicines Co. (MDCO) Misses Q1 EPS by 20c
April 26, 2017 7:17 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($1.44), $0.20 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $34.08 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More